Syntheses of syn- and anti-1,2-Amino Alcohols
J . Org. Chem., Vol. 67, No. 4, 2002 1053
2H), 1.67 (m, 1H), 1.92 (m, 2H), 2.51 (m, 2H), 2.61 (t, 2H, J )
7.4 Hz), 4.38 (m, 1H), 5.09 (s, 2H), 5.28 (d, 1H, J ) 8.0 Hz),
7.18-7.34 (m, 10H); 13C NMR δ 21.7, 23.3, 24.9, 35.0, 38.9,
40.7, 58.3, 66.9, 126.0, 128.1, 128.5, 129.0, 141.4, 156.1, 209.6.
(1S-Ben zyl-2-oxod ecyl)ca r ba m ic a cid 9H-flu or en -9-yl-
m eth yl ester (1f) was prepared by method A. Alkylation of
1173 mg (2.50 mmol) of 2f with 620 g (2.50 mmol) of heptyl
triflate afforded 785 mg (65%) of 1f as a colorless solid after
purification on silica gel eluting with 85:15 hexanes/EtOAc.
Pure material could be obtained by recrystallization from
hexanes: mp 104 °C; [R]20D +35.0 (c 1.00, CH2Cl2); FTIR (KBr)
method A afforded 98 mg (98%) of crude anti-3a as a colorless
solid that could be purified by recrystallization from hexanes
with 90% recovery: mp 142 °C; [R]23 -21.4 (c 1.00, CH2Cl2);
D
FTIR (KBr) 3324, 1692 cm-1; H NMR δ 0.86 (t, 3H, J ) 6.5
1
Hz), 1.27 (m, 11H), 1.49 (m, 3H), 2.00 (s, 1H), 2.75 (dd, 1H, J
) 4.6, 14.1 Hz), 2.92 (dd, 1H, J ) 9.4, 14.1 Hz), 3.70 (m, 1H),
3.90 (m, 1H), 4.85 (d, 1H, J ) 6.2 Hz), 5.00 (s, 1H), 7.20-7.31
(m, 10H); 13C NMR δ 14.4, 23.0, 26.4, 29.6, 29.9, 30.0, 32.2,
33.9, 35.7, 57.4, 67.1, 74.3, 126.8, 128.3, 128.8, 128.9, 129.6,
136.8, 138.4, 156.9. Anal. Calcd for C25H35NO3: C, 75.53; H,
8.87; N, 3.52. Found: C, 75.65; H, 8.80; N, 3.58.
1725, 1691 cm-1
;
1H NMR δ 0.88 (t, 3H, J ) 6.6 Hz), 1.23
(1S-Ben zyl-2R-h yd r oxy-4-p h en ylbu tyl)ca r ba m ic Acid
2,2-Dim eth ylp r op yl Ester (a n ti-3b). Reduction of 1b (90
mg, 0.25 mmol) using method A afforded 84 (93%) mg of crude
anti-3b as a colorless solid that could be purified by recrys-
(broad, 10H), 1.53 (m, 2H), 2.37 (m, 2H), 3.04 (m, 2H), 4.18
(m, 1H), 4.38 (m, 2H), 4.62 (m, 1H), 5.43 (d, 1H, J ) 7.6 Hz),
7.12-7.77 (m, 13H); 13C NMR δ 14.1, 22.7, 23.4, 29.1, 29.3,
31.7, 38.0, 40.9, 47.3, 60.4, 67.0, 120.1, 125.1, 127.1, 127.9,
128.7, 129.3, 136.0, 141.4, 143.9, 155.7, 208.8. Anal. Calcd for
tallization from ethyl acetate with 86% recovery: mp 163 °C;
1
[R]23 -1.4 (c 1.00, CH2Cl2); FTIR (KBr) 3360, 1688 cm-1; H
D
C
32H37NO3: C, 79.47; H, 7.71; N, 2.90. Found: C, 79.60; H,
NMR δ 1.35 (s, 9H), 1.83 (m, 2H), 2.68 (m, 2H), 2.91 (m, 2H),
3.72 (m, 1H), 3.84 (m, 1H), 4.60 (d, 1H, J ) 8.1 Hz), 7.15-
7.30 (m, 10H); 13C NMR δ 28.3, 32.4, 35.2, 36.9, 57.1, 73.5,
79.8, 126.0, 126.4, 128.6, 129.3, 138.1, 142.0, 156.4. Anal. Calcd
for C22H29NO3: C, 74.33; H, 8.22; N, 3.94. Found: C, 74.19;
H, 8.03; N, 3.99.
7.63; N, 3.04.
4S-ter t-Bu toxycar bon ylam in o-9-m eth yl-5-oxodec-8-en o-
ic a cid m eth yl ester (1g) was prepared by method B.
Alkylation of 1063 mg (3.1 mmol) of 2g with 462 mg (3.1 mmol)
of prenyl bromide afforded 720 mg (71%) of 1g as a colorless
oil after purification on silica gel eluting with 90:10 hexanes/
EtOAc: [R]20D +29.7 (c 1.00, CH2Cl2); FTIR (CHCl3) 3435, 3026,
2986, 2927, 1741, 1710, 1506, 1451, 1381, 1182 cm-1; 1H NMR
δ 1.43 (s, 9H), 1.61 (s, 3H), 1.67 (s, 3H), 1.73 (m, 2H), 2.29 (m,
2H), 2.31 (m, 2H), 2.54 (m, 2H), 3.68 (s, 3H), 4.35 (m, 1H),
5.04 (t, 1H, J ) 7.1 Hz), 5.25 (d, 1H, J ) 8.0 Hz); 13C NMR δ
17.7, 22.3, 25.6, 26.8, 28.3, 29.7, 39.8, 51.7, 58.6, 79.9, 122.4,
133.1, 155.5, 173.3, 208.5.
(2R-Hydr oxy-1S-m eth yl-5-ph en ylpen tyl)car bam ic Acid
2,2-Dim eth ylp r op yl Ester (a n ti-3c). Reduction of 1c (73 mg,
0.25 mmol) using method A afforded 71 mg (97%) of crude anti-
3c as a colorless solid that could be purified by recrystallization
from hexanes with 92% recovery: mp 79 °C; [R]23D -8.2 (c 1.00,
CH2Cl2); FTIR (KBr) 3356, 1684 cm-1; 1H NMR δ 1.05 (d, 3H,
J ) 6.9 Hz), 1.43 (s, 9H), 1.64 (m, 2H), 1.82 (m, 2H), 2.25 (s,
1H), 2.64 (t, 2H, J ) 7.6 Hz), 3.64 (m, 2H), 4.77 (broad, 1H),
7.15-7.27 (m, 5H); 13C NMR δ 14.5, 27.8, 28.5, 32.8, 35.8, 50.8,
74.4, 79.6, 125.8, 128.4, 128.5, 142.2, 155.9. Anal. Calcd for
(1S-Ben zyloxym eth yl-2-oxod ecyl)ca r ba m ic a cid ben -
zyl ester (1h ) was prepared by method A. Alkylation of 1070
mg (2.60 mmol) of 2h with 1.85 g (2.86 mmol, 1.1 equiv) of
heptyl triflate afforded 818 mg (74%) of 1h as a colorless oil
after purification on silica gel eluting with 90:10 hexanes/
C
17H27NO3: C, 69.59; H, 9.28; N, 4.77. Found: C, 69.72; H,
9.15; N, 4.86.
(5S-ter t-Bu toxyca r bon yla m in o-6R-h yd r oxy-8-p h en yl-
octyl)ca r ba m ic Acid Ben zyl Ester (a n ti-3d ). Reduction of
1d (130 mg, 0.28 mmol) using method A afforded 127 mg (97%)
of crude anti-3d as a colorless solid that could be purified by
recrystallization from EtOH with 85% recovery: mp 113 °C;
[R]20D -15.8 (c 1.00, CH2Cl2); FTIR (KBr) 3366, 1696 cm-1; 1H
NMR δ 1.42 (broad, 15H), 1.70 (m, 2H), 2.48 (broad, 1H), 2.69
(m, 2H), 2.84 (m, 1H), 3.16 (m, 2H), 3.61 (m, 2H), 4.76 (broad,
1H), 4.89 (broad, 1H), 5.09 (s, 2H), 7.21-7.34 (m, 10H); 13C
NMR δ 23.1, 28.4, 29.1, 29.8, 32.4, 35.0, 40.7, 55.4, 66.7, 74.1,
79.7, 118.6, 125.9, 127.6, 128.0, 128.4, 136.6, 142.0, 156.6.
(2R-Hydr oxy-1S-isobu tyl-5-ph en ylpen tyl)car bam ic Acid
Ben zyl Ester (a n ti-3e). Reduction of 1e (200 mg, 0.56 mmol)
using method A afforded 159 mg (97%) of crude anti-3e as a
colorless solid that could be purified by recrystallization from
EtOAc: [R]21 +5.01 (c 1.00, CH2Cl2); FTIR (KBr) 1785, 1730,
D
1666 cm-1; 1H NMR δ 0.88 (t, 3H, J ) 6.0 Hz), 1.24 (m, 10H),
1.53 (m, 2H), 2.45 (m, 2H), 3.69 (dd, 1H, 3.3, 9.8 Hz), 3.90 (dd,
1H, 4.0, 9.9 Hz), 4.45 (m, 3H), 5.10 (s, 2H), 5.80 (d, 1H, J )
7.9 Hz), 7.25-7.31 (m, 10H); 13C NMR δ 14.1, 22.7, 23.4, 29.2,
29.5, 29.7, 31.8, 39.8, 60.3, 67.0, 69.7, 73.3, 127.4, 127.6, 128.1,
128.2, 128.3, 128.5, 128.6, 137.4, 156.0, 207.1. These data are
consistent with literature data.12b
Gen er a l P r oced u r e for th e P r ep a r a tion of th e Ca r -
bam ic N-P r otected a n ti-r-Am in o Alcoh ols (3a-h ). Meth od
A. LiAlH(O-t-Bu)3 (127 mg, 0.50 mmol) was dissolved in EtOH
(3 mL) at -78 °C under nitrogen, and then a solution of the
ketone 1a -h (0.25 mmol) in EtOH (4 mL) was added dropwise.
After 2 h, the solution was quenched with 10% citric acid (2
mL), extracted with ethyl acetate (2 × 50 mL), washed with
H2O (20 mL) and brine (20 mL), dried (MgSO4), and concen-
trated to provide a white solid that could be recrystallized from
an appropriate solvent.
Met h od B. NaBH4 (19 mg, 0.50 mmol) was dissolved in
EtOH (3 mL) at -78 °C under nitrogen, and a solution of the
ketone 1a (0.25 mmol) in EtOH (4 mL) was added dropwise.
After 2 h, the solution was quenched with 10% citric acid (2
mL), extracted with ethyl acetate (2 × 50 mL), washed with
H2O (20 mL) and brine (20 mL), dried (MgSO4), and concen-
trated to provide a white solid, which could be recrystallized
from an appropriate solvent. Other borohydride reagents were
used in place of sodium borohydride to generate the data in
Table 1.
Meth od C. A Selectride solution in THF (1 M, 0.5 mL) was
cooled at -78 °C under nitrogen, and then a solution of the
ketone 1a (100 mg, 0.25 mmol) in THF was added dropwise.
After 2 h, the solution was quenched with 10% citric acid (2
mL), extracted with ethyl acetate (2 × 50 mL), washed with
H2O (20 mL) and brine (20 mL), dried (MgSO4), passed through
a short pad of silica gel, and concentrated to provide the crude
product, which coul be recrystallized from an appropriate
solvent.
hexanes with 87% recovery: mp 108 °C; [R]20 -35.6 (c 1.00,
D
CH2Cl2); FTIR (KBr) 3325, 1696 cm-1; 1H NMR δ 0.90 (d, 6H,
J ) 6.4 Hz), 1.23 (m, 2H), 1.40 (m, 2H), 1.61 (m, 2H), 1.84 (m,
1H), 2.25 (broad, 1H), 2.63 (t, 2H, J ) 7.7 Hz), 3.67 (m, 2H),
4.86 (d, 1H, J ) 8.2 Hz), 5.08 (s, 2H), 7.14-7.33 (m, 10H); 13
C
NMR δ 21.6, 23.7, 24.7, 27.8, 32.5, 35.8, 38.1, 54.0, 66.9, 74.6,
125.8, 128.1, 128,4, 128.5, 136.5, 142.2, 156.8. Anal. Calcd for
C
23H31NO3: C, 74.76; H, 8.46; N, 3.79. Found: C, 74.61; H,
8.35; N, 3.89.
(1S-Ben zyl-2R-h yd r oxyd ecyl)ca r ba m ic Acid 9H-F lu o-
r en -9-ylm eth yl Ester (a n ti-3f). Reduction of 1f (100 mg, 0.20
mmol) using method A afforded 95 mg (95%) of crude anti-3f
as a colorless solid that could be purified by recrystallization
from EtOH with 85% recovery: mp 172 °C; [R]20D -20.8 (c 1.00,
1
CH2Cl2); FTIR (KBr) 3335, 1696 cm-1; H NMR (DMSO-d6) δ
1.23 (t, 3H, J ) 6.2 Hz), 1.62 (broad, 12H), 1.85 (m, 2H), 2.90
(m, 2H), 2.96 (m 1H), 3.42 (dd, 1H, J ) 13.5, 2.3 Hz), 3.83 (m,
1H), 4.51 (m, 3H), 5.09 (d, 1H, J ) 6.3 Hz), 7.55-8.30 (m, 13H);
13C NMR (DMSO-d6) δ 14.1, 22.2, 25.7, 29.3, 31.4, 32.1, 33.5,
35.9, 57.0, 57.6, 73.1, 73.5, 109.9, 120.2, 121.6, 125.9, 127.5,
128.2, 129.2, 135.5, 140.5, 157.1. Anal. Calcd for C32H39NO3:
C, 79.14; H, 8.09; N, 2.88. Found: C, 78.97; H, 7.95; N, 2.92.
4S-ter t-Bu toxycar bon ylam in o-5R-h ydr oxy-9-m eth yldec-
8-en oic Acid Meth yl Ester (a n ti-3g). Reduction of 1g (100
mg, 0.30 mmol) using method A afforded 96 mg (96%) of crude
(1S-Ben zyl-2R-h yd r oxyd ecyl)ca r ba m ic Acid Ben zyl
Ester (a n ti-3a ). Reduction of 1a (100 mg, 0.25 mmol) using